Planning Strategies’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$379 Sell
32
-3
-9% -$39 ﹤0.01% 987
2026
Q2
$455 Buy
+35
New +$782 ﹤0.01% 874

Other funds holding GOSS

Planning Strategies's GOSS Position: Q3 2026 in Review

Planning Strategies reduced its Gossamer Bio (GOSS) stake by 8.6% in Q3 2026, selling an estimated $39 and leaving 32 shares worth $379. The position accounts for ﹤0.01% of the portfolio, ranked #987.

Planning Strategies first reported a position in GOSS in Q2 2026 and has held it in 2 quarters since. The position peaked at $455 in Q2 2026. 76 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Planning Strategies held 32 shares of Gossamer Bio worth $379 as of Q3 2026.
  • Planning Strategies sold 3 Gossamer Bio shares in Q3 2026, an estimated $39.
  • Gossamer Bio made up ﹤0.01% of Planning Strategies's portfolio in Q3 2026, its #987 holding.
  • Planning Strategies first reported a position in Gossamer Bio in Q2 2026 and has held it in 2 quarters since.
  • Planning Strategies's Gossamer Bio position peaked at $455 in Q2 2026.
  • 76 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Planning Strategies's 13F filing for Q3 2026, filed 2 Oct 2026.